Pzena Investment Management LLC Purchases Shares of 603,206 Teleflex Incorporated $TFX

Key Points

• Pzena Investment Management acquired 603,206 Teleflex shares worth approximately $76.5 million, representing about 1.36% of the company. Institutional investors collectively own 95.62% of Teleflex.
• Teleflex reported quarterly EPS of $1.76, exceeding the $1.28 consensus estimate, while revenue rose 28.9% year over year to $570.33 million. The company issued fiscal 2026 EPS guidance of $6.90 to $7.20.
• Analysts maintain a mixed outlook, with the stock carrying an average rating of “Hold” and a consensus price target of $151.80 versus its reported trading price of $133.05. Teleflex also declared a quarterly dividend of $0.34 per share, equating to a 1.0% annualized yield.

Pzena Investment Management LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 603,206 shares of the medical technology company's stock, valued at approximately $76,462,000. Pzena Investment Management LLC owned about 1.36% of Teleflex as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Kelleher Financial Advisors bought a new position in shares of Teleflex during the second quarter worth approximately $25,000. Banque Cantonale Vaudoise lifted its holdings in Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock worth $31,000 after purchasing an additional 113 shares during the last quarter. UMB Bank n.a. boosted its stake in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company's stock valued at $38,000 after purchasing an additional 113 shares during the period. Kestra Advisory Services LLC bought a new stake in Teleflex in the 4th quarter valued at $45,000. Finally, Hantz Financial Services Inc. grew its holdings in Teleflex by 40.5% in the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company's stock valued at $48,000 after buying an additional 113 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Trading Down 3.0%

Shares of Teleflex stock opened at $133.05 on Tuesday. The company has a quick ratio of 2.12, a current ratio of 2.60 and a debt-to-equity ratio of 0.94. Teleflex Incorporated has a 12-month low of $100.18 and a 12-month high of $145.00. The company has a market capitalization of $5.64 billion, a price-to-earnings ratio of -5.71, a PEG ratio of 0.91 and a beta of 0.81. The firm's 50-day moving average price is $132.40 and its two-hundred day moving average price is $124.01.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company had revenue of $570.33 million during the quarter, compared to analysts' expectations of $559.59 million. During the same period in the previous year, the company earned $3.73 EPS. The business's revenue for the quarter was up 28.9% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. On average, analysts forecast that Teleflex Incorporated will post 7.26 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex's payout ratio is currently -5.84%.

Analyst Ratings Changes

Several research firms have weighed in on TFX. Piper Sandler reiterated an "overweight" rating and set a $169.00 price objective (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. Wells Fargo & Company upped their price target on shares of Teleflex from $130.00 to $138.00 and gave the company an "equal weight" rating in a research note on Friday, May 8th. Raymond James Financial reaffirmed an "outperform" rating and set a $150.00 price target on shares of Teleflex in a research report on Friday, May 8th. Mizuho lifted their price objective on shares of Teleflex from $140.00 to $145.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 15th. Finally, BMO Capital Markets assumed coverage on shares of Teleflex in a report on Wednesday, July 8th. They issued an "outperform" rating and a $159.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $151.80.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source